Kristen N Ganjoo

My research has focused on rare, monogenetic skin diseases such as Epidermolysis Bullosa (EB) and Gorlin Syndrome (Basal Cell Nevus Syndrome). With my PhD training in basic science, post-doctoral fellowship in clinical research, and residency in dermatology, I am committed to improving the lives of EB patients, to correct their underlying genetic disease and to offer new treatments for their skin and esophageal wounds. I was the PI of the investigator-initiated, Phase 1/2A clinical trial of autologous gene-therapy skin grafts for RDEB (Pz-cel, EB-101, previously called LEAES).

Dr. Wapnir’s work in the field of breast oncology spans clinical and translational research. Her past bench research centered on elucidating the activity of the sodium iodide symporter in lactation and breast cancer. She conducted studies on the impact of breast cancer locoregional recurrences with colleagues from the NSABP (NRG Oncology) Cooperative Oncology Group. Based on these, she co-chaired the CALOR (Chemotherapy for isolated locoregional recurrence of breast cancer) trial, that has since defined the use of systemic therapies for this patient population. Nationally, she has been continuously engaged in clinical trials as a member of the NRG Breast Locoregional Subcommittee and NCI-BOLD Task Force.

A. Dimitrios Colevas, MD, is a distinguished medical oncologist specializing in head and neck cancers, as well as cutaneous oncology. He holds a professorship in Medicine and is affiliated with the departments of Otolaryngology-Head and Neck Surgery and Radiation Oncology. Dr. Colevas completed his medical education and residency at Johns Hopkins University School of Medicine and has extensive experience in clinical trials and research related to squamous cell carcinoma. His contributions to oncology are well-documented through numerous publications and studies in esteemed medical journals. Generated from the website